• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有周期性治疗的 Gompertz 模型及其在前列腺癌中的应用。

Gompertz models with periodical treatment and applications to prostate cancer.

机构信息

Department of Mathematics, University of Miami, 1365 Memorial Drive, Coral Gables, FL 33146, USA.

出版信息

Math Biosci Eng. 2024 Feb 23;21(3):4104-4116. doi: 10.3934/mbe.2024181.

DOI:10.3934/mbe.2024181
PMID:38549320
Abstract

In this paper, Gompertz type models are proposed to understand the temporal tumor volume behavior of prostate cancer when a periodical treatment is provided. Existence, uniqueness, and stability of periodic solutions are established. The models are used to fit the data and to forecast the tumor growth behavior based on prostate cancer treatments using capsaicin and docetaxel anticancer drugs. Numerical simulations show that the combination of capsaicin and docetaxel is the most efficient treatment of prostate cancer.

摘要

本文提出了戈珀特(Gompertz)型模型,以了解周期性治疗时前列腺癌的肿瘤体积随时间的变化行为。建立了周期解的存在性、唯一性和稳定性。利用这些模型对使用辣椒素和多西紫杉醇抗癌药物的前列腺癌治疗数据进行拟合,并对肿瘤生长行为进行预测。数值模拟表明,辣椒素和多西紫杉醇的联合治疗是治疗前列腺癌最有效的方法。

相似文献

1
Gompertz models with periodical treatment and applications to prostate cancer.具有周期性治疗的 Gompertz 模型及其在前列腺癌中的应用。
Math Biosci Eng. 2024 Feb 23;21(3):4104-4116. doi: 10.3934/mbe.2024181.
2
Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence.基于交联多酚的药物纳米自组装体,旨在阻断前列腺癌衰老。
ACS Appl Mater Interfaces. 2019 Oct 23;11(42):38537-38554. doi: 10.1021/acsami.9b14738. Epub 2019 Oct 8.
3
The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines.转录因子 ZEB1 促进前列腺癌细胞系的化疗耐药性。
Asian J Androl. 2019 Sep-Oct;21(5):460-467. doi: 10.4103/aja.aja_1_19.
4
ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer.ATM/NEMO 信号转导调节多西他赛化疗后前列腺癌细胞程序性死亡配体 1 的表达。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2020-001758.
5
Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs.多西紫杉醇耐药在前列腺癌中的机制:miRNAs 发挥的关键作用。
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188481. doi: 10.1016/j.bbcan.2020.188481. Epub 2020 Nov 17.
6
Combined effect of sodium selenite and docetaxel on PC3 metastatic prostate cancer cell line.亚硒酸钠与多西紫杉醇联合作用对 PC3 转移性前列腺癌细胞系的影响。
Biochem Biophys Res Commun. 2011 May 20;408(4):713-9. doi: 10.1016/j.bbrc.2011.04.109. Epub 2011 Apr 28.
7
STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel.STEAP1 敲低降低前列腺癌细胞对紫杉醇、多西他赛和卡巴他赛的敏感性。
Int J Mol Sci. 2023 Apr 2;24(7):6643. doi: 10.3390/ijms24076643.
8
Chemotherapy, not androgen receptor-targeted therapy should be used upfront for metastatic hormone-sensitive prostate cancer. PRO: docetaxel chemotherapy should be the default consideration in metastatic hormone-sensitive prostate cancer.对于转移性激素敏感性前列腺癌,应首选化疗而非雄激素受体靶向治疗。正方观点:多西他赛化疗应作为转移性激素敏感性前列腺癌的默认治疗方案。
Curr Opin Urol. 2020 Jul;30(4):617-619. doi: 10.1097/MOU.0000000000000777.
9
Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells.基因表达谱分析揭示了多西他赛和雌莫司汀联合治疗前列腺癌细胞的新分子靶点。
Mol Cancer Ther. 2005 Mar;4(3):389-98. doi: 10.1158/1535-7163.MCT-04-0244.
10
Induction of Endoplasmic Reticulum Stress-Mediated Apoptosis by Aminosteroid RM-581 Efficiently Blocks the Growth of PC-3 Cancer Cells and Tumors Resistant or Not to Docetaxel.氨甾体 RM-581 通过诱导内质网应激介导的细胞凋亡有效抑制对多西他赛耐药或不耐药的 PC-3 癌细胞及肿瘤的生长。
Int J Mol Sci. 2021 Oct 17;22(20):11181. doi: 10.3390/ijms222011181.

引用本文的文献

1
Mathematic Modeling of Tumor Growth During [Lu]Lu-PSMA Therapy: Insights into Treatment Optimization.[镥]镥-PSMA治疗期间肿瘤生长的数学建模:对治疗优化的见解
J Nucl Med. 2025 Jan 3;66(1):84-90. doi: 10.2967/jnumed.124.268457.